603669 灵康药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-4.585-15.377-14.668-15.1044.485
总资产报酬率 ROA (%)-2.809-9.081-8.707-8.9642.520
投入资产回报率 ROIC (%)-3.304-10.029-9.094-9.2602.622

边际利润分析
销售毛利率 (%)43.92346.88146.67267.80979.376
营业利润率 (%)-13.234-33.906-75.690-65.2269.608
息税前利润/营业总收入 (%)-6.824-33.207-76.447-65.67010.385
净利润/营业总收入 (%)-12.241-34.431-76.967-67.7118.902

收益指标分析
经营活动净收益/利润总额(%)134.23467.780103.96389.06648.031
价值变动净收益/利润总额(%)-4.2085.3399.6284.30023.916
营业外收支净额/利润总额(%)-8.115-0.8141.3080.069-0.920

偿债能力分析
流动比率 (X)3.1102.6753.6263.7432.756
速动比率 (X)2.8012.5483.3933.5812.676
资产负债率 (%)38.78738.68142.69038.84941.980
带息债务/全部投入资本 (%)27.85126.49839.19036.01039.555
股东权益/带息债务 (%)256.361274.441153.346176.783150.667
股东权益/负债合计 (%)157.815158.526134.249157.405138.208
利息保障倍数 (X)-1.260-78.049-310.910164.74512.006

营运能力分析
应收账款周转天数 (天)258.181145.938143.506134.24571.707
存货周转天数 (天)72.59775.527181.612194.865142.329